Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v5-EN
Language English English
Date Updated 2017-07-01 2017-06-21
Drug Identification Number 02439573 02439573
Brand name MINT-RIZATRIPTAN ODT MINT-RIZATRIPTAN ODT
Common or Proper name Rizatriptan Benzoate Rizatriptan Benzoate
Company Name MINT PHARMACEUTICALS INC MINT PHARMACEUTICALS INC
Ingredients RIZATRIPTAN RIZATRIPTAN
Strength(s) 5MG 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size Blister pack of 6 Tablets Blister pack of 6 Tablets
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-06-30 2017-06-30
Remaining supply date 2017-06-30 2017-06-30
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments